ITMI20040145A1 - L-moprololo lpiu' tartrato - Google Patents

L-moprololo lpiu' tartrato

Info

Publication number
ITMI20040145A1
ITMI20040145A1 IT000145A ITMI20040145A ITMI20040145A1 IT MI20040145 A1 ITMI20040145 A1 IT MI20040145A1 IT 000145 A IT000145 A IT 000145A IT MI20040145 A ITMI20040145 A IT MI20040145A IT MI20040145 A1 ITMI20040145 A1 IT MI20040145A1
Authority
IT
Italy
Prior art keywords
moprololo
lpiu
tartrato
moprolol
preparing
Prior art date
Application number
IT000145A
Other languages
English (en)
Inventor
Nicola Cazzolla
Caterina Maugeri
Mauro Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Priority to IT000145A priority Critical patent/ITMI20040145A1/it
Publication of ITMI20040145A1 publication Critical patent/ITMI20040145A1/it
Priority to DE602005026908T priority patent/DE602005026908D1/de
Priority to AT05701093T priority patent/ATE502003T1/de
Priority to AU2005211458A priority patent/AU2005211458B2/en
Priority to EA200601402A priority patent/EA200601402A1/ru
Priority to US10/584,261 priority patent/US7524886B2/en
Priority to ES05701093T priority patent/ES2361518T3/es
Priority to EP05701093A priority patent/EP1708987B1/en
Priority to PT05701093T priority patent/PT1708987E/pt
Priority to PCT/EP2005/000560 priority patent/WO2005075408A1/en
Priority to SI200531291T priority patent/SI1708987T1/sl
Priority to CA2550302A priority patent/CA2550302C/en
Priority to DK05701093.6T priority patent/DK1708987T3/da
Priority to CNB2005800023445A priority patent/CN100480232C/zh
Priority to PL05701093T priority patent/PL1708987T3/pl
Priority to KR1020067015321A priority patent/KR101122173B1/ko
Priority to JP2006550043A priority patent/JP4646922B2/ja
Priority to BRPI0507150-0A priority patent/BRPI0507150A/pt
Priority to IL176280A priority patent/IL176280A/en
Priority to HK06114156.5A priority patent/HK1093962A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Detergent Compositions (AREA)
IT000145A 2004-01-30 2004-01-30 L-moprololo lpiu' tartrato ITMI20040145A1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT000145A ITMI20040145A1 (it) 2004-01-30 2004-01-30 L-moprololo lpiu' tartrato
BRPI0507150-0A BRPI0507150A (pt) 2004-01-30 2005-01-14 composto, composição farmacêutica para uso oftálmico, e, processo para a preparação de l-(+) -tartarato de l-(-) -moprolol
PT05701093T PT1708987E (pt) 2004-01-30 2005-01-14 L-(-)-moprolol l-(+)-tartarato
SI200531291T SI1708987T1 (sl) 2004-01-30 2005-01-14 L-(-)-MOPROLOL l-(+)-tartrat
AU2005211458A AU2005211458B2 (en) 2004-01-30 2005-01-14 L-(-)-moprolol L-(+)-tartrate
EA200601402A EA200601402A1 (ru) 2004-01-30 2005-01-14 L-(+)-тартрат l-(-)- мопролола
US10/584,261 US7524886B2 (en) 2004-01-30 2005-01-14 L-(−)-moprolol L-(+)-tartrate
ES05701093T ES2361518T3 (es) 2004-01-30 2005-01-14 L-(-)-moprolol l-(+)-tartrato.
EP05701093A EP1708987B1 (en) 2004-01-30 2005-01-14 L-(-)-moprolol l-(+)-tartrate
DE602005026908T DE602005026908D1 (de) 2004-01-30 2005-01-14 L-(-)-moprolol-l-(+)-tartrat
PCT/EP2005/000560 WO2005075408A1 (en) 2004-01-30 2005-01-14 L-(-)-moprolol l-(+)-tartrate
AT05701093T ATE502003T1 (de) 2004-01-30 2005-01-14 L-(-)-moprolol-l-(+)-tartrat
CA2550302A CA2550302C (en) 2004-01-30 2005-01-14 L-(-)-moprolol l-(+)-tartrate
DK05701093.6T DK1708987T3 (da) 2004-01-30 2005-01-14 L-(-)-moprolol-L-(+)-tartrat
CNB2005800023445A CN100480232C (zh) 2004-01-30 2005-01-14 L-(-)-莫普洛尔l-(+)-酒石酸盐
PL05701093T PL1708987T3 (pl) 2004-01-30 2005-01-14 L-(+)-Winian L-(-)-moprololu
KR1020067015321A KR101122173B1 (ko) 2004-01-30 2005-01-14 Ｌ-(-)-모프롤롤 ｌ-(+)-타르타르산염
JP2006550043A JP4646922B2 (ja) 2004-01-30 2005-01-14 Ｌ−（−）−モプロロールｌ−（＋）−酒石酸塩を含む薬剤組成物及びその製造方法
IL176280A IL176280A (en) 2004-01-30 2006-06-13 L-(-)- moprolol l-(+)-tartrate
HK06114156.5A HK1093962A1 (en) 2004-01-30 2006-12-27 L-(-)-moprolol-l-(+)-tartrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000145A ITMI20040145A1 (it) 2004-01-30 2004-01-30 L-moprololo lpiu' tartrato

Publications (1)

Publication Number Publication Date
ITMI20040145A1 true ITMI20040145A1 (it) 2004-04-30

Family

ID=34835572

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000145A ITMI20040145A1 (it) 2004-01-30 2004-01-30 L-moprololo lpiu' tartrato

Country Status (20)

Country Link
US (1) US7524886B2 (it)
EP (1) EP1708987B1 (it)
JP (1) JP4646922B2 (it)
KR (1) KR101122173B1 (it)
CN (1) CN100480232C (it)
AT (1) ATE502003T1 (it)
AU (1) AU2005211458B2 (it)
BR (1) BRPI0507150A (it)
CA (1) CA2550302C (it)
DE (1) DE602005026908D1 (it)
DK (1) DK1708987T3 (it)
EA (1) EA200601402A1 (it)
ES (1) ES2361518T3 (it)
HK (1) HK1093962A1 (it)
IL (1) IL176280A (it)
IT (1) ITMI20040145A1 (it)
PL (1) PL1708987T3 (it)
PT (1) PT1708987E (it)
SI (1) SI1708987T1 (it)
WO (1) WO2005075408A1 (it)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1211589A (en) * 1968-08-06 1970-11-11 Ici Ltd Enantiomer isolation process
IT1113029B (it) 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
AR030414A1 (es) * 2000-04-03 2003-08-20 Astrazeneca Ab Combinacion farmaceutica que comprende un beta bloqueante y un inhibidor de hmg-coa reductasa , formulacion farmaceutica, equipo transportable de partes , uso de esta combinacion y de esta formulacion para preparar medicamentos

Also Published As

Publication number Publication date
HK1093962A1 (en) 2007-03-16
KR101122173B1 (ko) 2012-03-15
CA2550302A1 (en) 2005-08-18
CN1910138A (zh) 2007-02-07
JP2007519661A (ja) 2007-07-19
ATE502003T1 (de) 2011-04-15
WO2005075408A1 (en) 2005-08-18
CN100480232C (zh) 2009-04-22
EA200601402A1 (ru) 2006-12-29
US20080015258A1 (en) 2008-01-17
DK1708987T3 (da) 2011-06-27
EP1708987B1 (en) 2011-03-16
ES2361518T3 (es) 2011-06-17
CA2550302C (en) 2012-04-24
AU2005211458A1 (en) 2005-08-18
PL1708987T3 (pl) 2011-08-31
AU2005211458B2 (en) 2010-06-24
IL176280A (en) 2010-12-30
KR20070000451A (ko) 2007-01-02
IL176280A0 (en) 2006-10-05
PT1708987E (pt) 2011-05-31
SI1708987T1 (sl) 2011-06-30
JP4646922B2 (ja) 2011-03-09
EP1708987A1 (en) 2006-10-11
BRPI0507150A (pt) 2007-06-26
US7524886B2 (en) 2009-04-28
DE602005026908D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
NO20092611L (no) Krystallinsk faststoff Rasagilin base
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
NO20056132L (no) Krystallinsk form av beta2 adrenergisk receptoragonist
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
SE0200920D0 (sv) Novel compounds
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA05011522A (es) Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica.
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
TW200736227A (en) New compounds III
MX2007003897A (es) Una formulacion farmaceutica que comprende insulina cristalina e insulina disuelta.
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
EA200501164A1 (ru) Индазоламиды с аналгетической активностью
MX2007004461A (es) Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico.
MY138698A (en) Method for synthesis of (2s)-indoline-2-carboxylic acid, and use in the synthesis of perindopril
EA200501818A1 (ru) Индазолы, обладающие анальгетической активностью
ITMI20040145A1 (it) L-moprololo lpiu' tartrato
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
EA200601117A1 (ru) Малеат ибопамина, способ его получения и фармацевтические композиции на его основе
EA200701201A1 (ru) Новая фармацевтическая композиция для вакцин
SE0400522D0 (sv) A medical solution, a method for producing said medical solution and use thereof
SE0402459D0 (sv) New hydroxymethylbenzothiazoles amides
UA67614A (en) Antistress substance